Copyright © 1995 by the European Society of Cardiology.
© 1995 The European Society of Cardiology
Fibrinogen and Peripheral Arterial Disease
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh Edinburgh, U.K.
Correspondenc: F. G. R. Fowkes, Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh, U.K.
Both hospital and epidemiological studies have reported elevated plasma fibrinogen levels in patients with intermittent claudication. Fibrinogen levels have also been positively related to the degree of asymptomatic peripheral arterial disease (PAD). In claudicants, raised fibrinogen is predictive of future cardiovascular events, particularly coronary death. These associations between plasma fibrinogen and PAD are independent of diabetes mellitus and serum lipid concentrations. Lifetime cigarette smoking and plasma fibrinogen interact synergistically in their association with PAD. However, most of the increased risk of PAD due to cigarette smoking is not mediated via plasma fibrinogen, and conversely the relationship between fibrinogen and PAD is not wholly dependent on smoking. The association between fibrinogen and PAD is stronger in men than in women, and in women does not occur independently of smoking. When comparing sex differences in a wide range of aetiological factors associated with PAD, plasma fibrinogen is one of the few factors showing a stronger relationship in men than in women, and may be important in explaining sex differences in susceptibility to disease.
Key Words: Fibrinogen • peripheral arterial disease • intermittent claudication • ankle brachial pressure index • smoking • gender • lipoprotein • ischaemic heart disease
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]
|
|
|
|
 |
|
 Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Dawson, Qintian Zheng, S. A. Worthy, B. Charles, and D. V. Bradley Failure of Pentoxifylline or Cilostazol to Improve Blood and Plasma Viscosity, Fibrinogen, and Erythrocyte Deformability in Claudication Angiology, September 1, 2002; 53(5): 509 - 520. [Abstract] [PDF]
|
|
|
|
 |
|
 P. V Tisi and C. P Shearman Biochemical and inflammatory changes in the exercising claudicant Vascular Medicine, August 1, 1998; 3(3): 189 - 198. [Abstract] [PDF]
|
|